Titan Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TTNP and buy or sell other stocks, ETFs, and their options commission-free!About TTNP
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.
CEOWeei Jye Chay
CEOWeei Jye Chay
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1992
Founded1992
Employees—
Employees—
TTNP Key Statistics
Market cap23.98K
Market cap23.98K
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.76
52 Week high$5.76
52 Week low$3.58
52 Week low$3.58
Stock Snapshot
The current Titan Pharmaceuticals(TTNP) stock price is $23.98, with a market capitalization of 23.98K. The stock trades at a price-to-earnings (P/E) ratio of -0.01.
During the trading day, Titan Pharmaceuticals(TTNP) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Titan Pharmaceuticals(TTNP) stock has reached 0.
Over the past 52 weeks, Titan Pharmaceuticals(TTNP) stock has traded between a high of $5.76 and a low of $3.58.
Over the past 52 weeks, Titan Pharmaceuticals(TTNP) stock has traded between a high of $5.76 and a low of $3.58.
People also own
Based on the portfolios of people who own TTNP. This list is generated using Robinhood data, and it’s not a recommendation.